Skip to main content
. Author manuscript; available in PMC: 2014 Jan 13.
Published in final edited form as: Int J Oncol. 2011 Jun 16;39(4):891–898. doi: 10.3892/ijo.2011.1085

Figure 5.

Figure 5

Effects of cisplatin plus TRAIL treatment on the ability of cancer stem cells to form mammospheres. The in vitro mammosphere was quantified by counting the mammospheres after treatment with cisplatin, TRAIL and cisplatin plus TRAIL compared to controls. Cisplatin plus TRAIL treatment had maximum inhibition on the cancer stem cell ability to form mammospheres in CRL2335- (A) and MDA-MB-468- (B) derived CSCs. Salinomycin a well established CSC inhibitor was used as an internal control. Data are the mean ± SE of triplicate determinations.